{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:10:12Z","timestamp":1789150212725,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03517-0","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:39:32Z","timestamp":1789148372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design of Eudragit E100 Films Incorporating Lipoic Acid as a Permeability-Enhancing Platform for Prednisolone Delivery in the Treatment of Ophthalmic Diseases"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9235-2297","authenticated-orcid":false,"given":"Karina","family":"Bierbrauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5921-202X","authenticated-orcid":false,"given":"Laura","family":"Comini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4868-6289","authenticated-orcid":false,"given":"Marcos","family":"Cometto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3021-0792","authenticated-orcid":false,"given":"Aldana","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6050-7566","authenticated-orcid":false,"given":"Leandro","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9134-5475","authenticated-orcid":false,"given":"Vanina","family":"Alamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3087-2489","authenticated-orcid":false,"given":"Gabriela","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1377-9937","authenticated-orcid":false,"given":"Silvia","family":"Farf\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-0001","authenticated-orcid":false,"given":"Victoria","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-9068","authenticated-orcid":false,"given":"Dante","family":"Beltramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2636-2109","authenticated-orcid":false,"given":"Roxana","family":"Alasino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","volume":"157","author":"R Brusini","year":"2020","unstructured":"Brusini R, Varna M, Couvreur P. Advanced nanomedicines for the treatment of inflammatory diseases. Adv Drug Deliv Rev. 2020;157:161\u201378. https:\/\/doi.org\/10.1016\/j.addr.2020.07.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","volume":"11","author":"SA Gaballa","year":"2021","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11:866\u201393. https:\/\/doi.org\/10.1007\/s13346-020-00843-z.","journal-title":"Drug Deliv Transl Res"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"124226","DOI":"10.1016\/j.ijpharm.2024.124226","volume":"658","author":"S Fathi-Karkan","year":"2024","unstructured":"Fathi-Karkan S, Ramsheh NA, Arkaban H, Narooie-Noori F, Sargazi S, Mirinejad S, et al. Nanosuspensions in ophthalmology: overcoming challenges and enhancing drug delivery for eye diseases. Int J Pharm. 2024;658:124226. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124226.","journal-title":"Int J Pharm"},{"key":"3517_CR4","doi-asserted-by":"publisher","first-page":"105406","DOI":"10.1016\/j.jddst.2024.105406","volume":"92","author":"MA Attia","year":"2024","unstructured":"Attia MA, Eleraky NE, Abdelazeem K, Safwat MA. Prednisolone loaded-cationic nanoemulsion formulation for uveitis management. J Drug Deliv Sci Technol. 2024;92:105406. https:\/\/doi.org\/10.1016\/j.jddst.2024.105406.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","volume":"321","author":"C Jumelle","year":"2020","unstructured":"Jumelle C, Gholizadeh S, Annabib N, Dana R. Advances and limitations of drug delivery systems formulated as eye drops. J Control Release. 2020;321:1\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.057.","journal-title":"J Control Release"},{"key":"3517_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103712","volume":"75","author":"V Puri","year":"2022","unstructured":"Puri V, Kaur VP, Singh A, Singh C. Recent advances on drug delivery applications of mucopenetrative\/ mucoadhesive particles: a review. J Drug Deliv Sci Technol. 2022;75:103712. https:\/\/doi.org\/10.1016\/j.jddst.2022.103712.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105785","volume":"97","author":"A Chandel","year":"2024","unstructured":"Chandel A, Kandav G. Insights into ocular therapeutics: a comprehensive review of anatomy, barriers, diseases and nanoscale formulations for targeted drug delivery. J Drug Deliv Sci Technol. 2024;97:105785. https:\/\/doi.org\/10.1016\/j.jddst.2024.105785.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jconrel.2017.07.035","volume":"268","author":"L Lalu","year":"2017","unstructured":"Lalu L, Tambe V, Pradhan D, Nayak K, Bagchi S, Maheshwari R, et al. Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions. J Control Release. 2017;268:19\u201339. https:\/\/doi.org\/10.1016\/j.jconrel.2017.07.035.","journal-title":"J Control Release"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijpharm.2017.07.065","volume":"530","author":"A Madni","year":"2017","unstructured":"Madni A, Rahema MA, Tahira N, Sarfraza M, Jabara A, Rehmana M, et al. Non-invasive strategies for targeting the posterior segment of eye. Int J Pharm. 2017;530:326\u201345. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.065.","journal-title":"Int J Pharm"},{"key":"3517_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2017.08.067","volume":"531","author":"J Rodr\u00edguez Villanueva","year":"2017","unstructured":"Rodr\u00edguez Villanueva J, Rodr\u00edguez Villanueva L. Turning the screw even further to increase microparticle retention and ocular bioavailability of associated drugs: the bioadhesion goal. Int J Pharm. 2017;531:167\u201378. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.067.","journal-title":"Int J Pharm"},{"key":"3517_CR11","doi-asserted-by":"publisher","first-page":"114868","DOI":"10.1016\/j.addr.2023.114868","volume":"198","author":"L Li","year":"2023","unstructured":"Li L, Jia F, Wanga Y, Liu J, Tian Y, Sun X, et al. Trans-corneal drug delivery strategies in the treatment of ocular diseases. Adv Drug Deliv Rev. 2023;198:114868. https:\/\/doi.org\/10.1016\/j.addr.2023.114868.","journal-title":"Adv Drug Deliv Rev"},{"key":"3517_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ymeth.2024.12.008","volume":"234","author":"ML Formica","year":"2025","unstructured":"Formica ML, Pernochi Scerbo JM, Awde Alfonso HG, Palmieri PT, Ribotta J, Palma SD. Nanotechnological approaches to improve corticosteroids ocular therapy. Methods. 2025;234:152\u201377. https:\/\/doi.org\/10.1016\/j.ymeth.2024.12.008.","journal-title":"Methods"},{"key":"3517_CR13","doi-asserted-by":"publisher","first-page":"101403","DOI":"10.1016\/j.nanoso.2024.101403","volume":"40","author":"K Singh","year":"2024","unstructured":"Singh K, Singhal S, Pahwa S, Sethi VA, Sharma S, Singh P, et al. Nanomedicine and drug delivery: a comprehensive review of applications and challenges. Nano-Struct Nano-Objects. 2024;40:101403. https:\/\/doi.org\/10.1016\/j.nanoso.2024.101403.","journal-title":"Nano-Struct Nano-Objects"},{"key":"3517_CR14","doi-asserted-by":"publisher","first-page":"104317","DOI":"10.1016\/j.jddst.2023.104317","volume":"82","author":"V Srivastava","year":"2023","unstructured":"Srivastava V, Chary PS, Rajana N, Pardhi ER, Singh V, Khatri D, et al. Complex ophthalmic formulation technologies: advancement and future perspectives. J Drug Deliv Sci Technol. 2023;82:104317. https:\/\/doi.org\/10.1016\/j.jddst.2023.104317.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.msec.2016.05.060","volume":"67","author":"AK Sharma","year":"2016","unstructured":"Sharma AK, Arya A, Sahoo PK, Majumdar DK. Overview of biopolymers as carriers of antiphlogistic agents for treatment of diverse ocular inflammations. Mater Sci Eng C Mater Biol Appl. 2016;67:779\u201391. https:\/\/doi.org\/10.1016\/j.msec.2016.05.060.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"3517_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jconrel.2018.06.031","volume":"285","author":"JC Imperiale","year":"2018","unstructured":"Imperiale JC, Acosta GB, Sosnik A. Polymer-based carriers for ophthalmic drug delivery. J Control Release. 2018;285:106\u201341. https:\/\/doi.org\/10.1016\/j.jconrel.2018.06.031.","journal-title":"J Control Release"},{"key":"3517_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.drudis.2021.02.027","volume":"26","author":"S Gholizadeh","year":"2021","unstructured":"Gholizadeh S, Wang Z, Chen X, Reza Dana R, Annabi N. Advanced nanodelivery platforms for topical ophthalmic drug delivery. Drug Discov Today. 2021;26:1437\u201349. https:\/\/doi.org\/10.1016\/j.drudis.2021.02.027.","journal-title":"Drug Discov Today"},{"key":"3517_CR18","doi-asserted-by":"publisher","unstructured":"Katzer T, Chaves P, Bernardi A, Pohlmann A, Guterres SS, Ruver Beck RC. Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity. J. Microencapsul. 2014;1-10. https:\/\/doi.org\/10.3109\/02652048.2013.879930.","DOI":"10.3109\/02652048.2013.879930"},{"key":"3517_CR19","doi-asserted-by":"publisher","first-page":"113957","DOI":"10.1016\/j.addr.2021.113957","volume":"177","author":"H Abdelkader","year":"2021","unstructured":"Abdelkader H, Fathalla Z, Seyfoddin A, Farahani M, Thrimawithana T, Allahham A, et al. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: inserts, patches, wafers, and implants. Adv Drug Deliv Rev. 2021;177:113957. https:\/\/doi.org\/10.1016\/j.addr.2021.113957.","journal-title":"Adv Drug Deliv Rev"},{"key":"3517_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejpb.2021.02.007","volume":"161","author":"P Chaudhari","year":"2021","unstructured":"Chaudhari P, Ghate VM, Lewis SA. Next-generation contact lenses: towards bioresponsive drug delivery and smart technologies in ocular therapeutics. Eur J Pharm Biopharm. 2021;161:80\u201399. https:\/\/doi.org\/10.1016\/j.ejpb.2021.02.007.","journal-title":"Eur J Pharm Biopharm"},{"key":"3517_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jconrel.2022.02.014","volume":"343","author":"AF Pereira-da-Mota","year":"2022","unstructured":"Pereira-da-Mota AF, Phan CM, Concheiro A, Jones L, Alvarez-Lorenzo C. Testing drug release from medicated contact lenses: the missing link to predict in vivo performance. J Control Release. 2022;343:672\u2013702. https:\/\/doi.org\/10.1016\/j.jconrel.2022.02.014.","journal-title":"J Control Release"},{"key":"3517_CR22","doi-asserted-by":"publisher","first-page":"122740","DOI":"10.1016\/j.ijpharm.2023.122740","volume":"638","author":"B Abdi","year":"2023","unstructured":"Abdi B, Mofidfar M, Hassanpour F, Cilingir EK, Kalajahi SK, Milani PH, et al. Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: advances in extended and targeted drug delivery. Int J Pharm. 2023;638:122740. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122740.","journal-title":"Int J Pharm"},{"key":"3517_CR23","doi-asserted-by":"publisher","first-page":"105503","DOI":"10.1016\/j.ejps.2020.105503","volume":"154","author":"C Torres-Luna","year":"2020","unstructured":"Torres-Luna C, Fan X, Domszy R, Hu N, Sun Wanga N, Yang A. Hydrogel-based ocular drug delivery systems for hydrophobic drugs. Eur J Pharm Sci. 2020;154:105503. https:\/\/doi.org\/10.1016\/j.ejps.2020.105503.","journal-title":"Eur J Pharm Sci"},{"key":"3517_CR24","doi-asserted-by":"publisher","first-page":"102342","DOI":"10.1016\/j.cis.2020.102342","volume":"288","author":"B Grassiri","year":"2021","unstructured":"Grassiri B, Zambito Y, Bernkop-Schn\u00fcrch A. Strategies to prolong the residence time of drug delivery systems on ocular surface. Adv Colloid Interface Sci. 2021;288:102342. https:\/\/doi.org\/10.1016\/j.cis.2020.102342.","journal-title":"Adv Colloid Interface Sci"},{"key":"3517_CR25","doi-asserted-by":"publisher","first-page":"104385","DOI":"10.1016\/j.jddst.2023.104385","volume":"83","author":"M Ghanavi","year":"2023","unstructured":"Ghanavi M, Khoshandam A, Aslzad S, Fathi M, Barzegari A, Abdolahinia ED, et al. Injectable thermosensitive PEG-g-chitosan hydrogel for ocular delivery of vancomycin and prednisolone. J Drug Deliv Sci Technol. 2023;83:104385. https:\/\/doi.org\/10.1016\/j.jddst.2023.104385.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR26","doi-asserted-by":"publisher","first-page":"104558","DOI":"10.1016\/j.jddst.2023.104558","volume":"84","author":"I Karnik","year":"2023","unstructured":"Karnik I, Youssef AAA, Joshi P, Munnangi SR, Narala S, Varner C, et al. Formulation development and characterization of dual drug loaded hot-melt extruded inserts for better ocular therapeutic outcomes: sulfacetamide\/prednisolone. J Drug Deliv Sci Technol. 2023;84:104558. https:\/\/doi.org\/10.1016\/j.jddst.2023.104558.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR27","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/polym15071793","volume":"15","author":"KL Bierbrauer","year":"2023","unstructured":"Bierbrauer KL, Comini LR, Leonhard V, Escobar Manzanelli MA, Castelli G, Farf\u00e1n S, et al. Eudragit films as carriers of lipoic acid for transcorneal permeability. Polymers. 2023;15:1793. https:\/\/doi.org\/10.3390\/polym15071793.","journal-title":"Polymers"},{"key":"3517_CR28","doi-asserted-by":"publisher","unstructured":"Patra Ch N, Priya R, Swain S, Kumar Jena G, Charan Panigrahi K, Ghose D. Pharmaceutical significance of Eudragit: A review. Future J Pharm Sci 2017;3:33e45. https:\/\/doi.org\/10.1016\/j.fjps.2017.02.001.","DOI":"10.1016\/j.fjps.2017.02.001"},{"key":"3517_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jddst.2016.04.009","volume":"35","author":"K Korhonen","year":"2016","unstructured":"Korhonen K, Poikolainen M, Korhonen O, Ketolainen J, Laitinen R. Evaluation of a novel spraying method for preparing Eudragit-polymer-drug thin matrix films by design of experiment. J Drug Deliv Sci Technol. 2016;35:241\u201351. https:\/\/doi.org\/10.1016\/j.jddst.2016.04.009.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR30","doi-asserted-by":"publisher","first-page":"114582","DOI":"10.1016\/j.addr.2022.114582","volume":"191","author":"N Nagai","year":"2022","unstructured":"Nagai N, Otake H. Novel drug delivery systems for the management of dry eye. Adv Drug Deliv Rev. 2022;191:114582. https:\/\/doi.org\/10.1016\/j.addr.2022.114582.","journal-title":"Adv Drug Deliv Rev"},{"key":"3517_CR31","doi-asserted-by":"publisher","first-page":"105867","DOI":"10.1016\/j.jddst.2024.105867","volume":"98","author":"L Zhang","year":"2024","unstructured":"Zhang L, Tian C, Zhao C, Wang G, Pei M, Sun C, et al. Resveratrol and lipoic acid: a promising combination for treating dry eye disease. J Drug Deliv Sci Technol. 2024;98:105867. https:\/\/doi.org\/10.1016\/j.jddst.2024.105867.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR32","doi-asserted-by":"publisher","unstructured":"Mateo Orobia AJ, Ben\u00edtez del Castillo JM, Calonge M, Baudouin C, Labetoulle M. A narrative literature review about alpha-lipoic acid role in dry eye and ocular surface disease. Acta Ophthalmol. 2025;e346-e363:1\u201318. https:\/\/doi.org\/10.1111\/aos.17486.","DOI":"10.1111\/aos.17486"},{"key":"3517_CR33","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1016\/j.xphs.2016.03.006","volume":"105","author":"F Alvarez-Rivera","year":"2016","unstructured":"Alvarez-Rivera F, Fernandez-Villanueva D, Concheiro A, Alvarez-Lorenzo C. a-lipoic acid in soluplus\u00ae polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases. J Pharm Sci. 2016;105:2855\u201363. https:\/\/doi.org\/10.1016\/j.xphs.2016.03.006.","journal-title":"J Pharm Sci"},{"key":"3517_CR34","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3390\/molecules30091972","volume":"30","author":"Y Wang","year":"2025","unstructured":"Wang Y, Jiang S, He Y, Pang P, Shan H. Advances in \u03b1-lipoic acid for disease prevention: mechanisms and therapeutic insights. Molecules. 2025;30:1972. https:\/\/doi.org\/10.3390\/molecules30091972.","journal-title":"Molecules"},{"key":"3517_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.31083\/j.fbl2707202","volume":"27","author":"AM Roszkowska","year":"2022","unstructured":"Roszkowska AM, Spinella R, Oliverio GW, Postorino EI, Signorino GA, Rusciano D, et al. Effects of the topical use of the natural antioxidant alpha-lipoic acid on the ocular surface of diabetic patients with dry eye symptoms. Front Biosci (Landmark Ed). 2022;27:202. https:\/\/doi.org\/10.31083\/j.fbl2707202.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"3517_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jddst.2017.12.020","volume":"44","author":"P Khatri","year":"2018","unstructured":"Khatri P, Desai D, Shelke N, Minko T. Role of plasticizer in membrane coated extended release oral drug delivery system. J Drug Deliv Sci Technol. 2018;44:231\u201343. https:\/\/doi.org\/10.1016\/j.jddst.2017.12.020.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3517_CR37","doi-asserted-by":"publisher","unstructured":"Jouyban A, Shayanfar A, Panahi-Azar V, Soleymani J, Yousefi BH, Acree WE JR, et al. Solubility prediction of drugs in mixed solvents using partial solubility parameters. J Pharm Sci. 2011;100:4368\u201382. https:\/\/doi.org\/10.1002\/jps.22589.","DOI":"10.1002\/jps.22589"},{"key":"3517_CR38","unstructured":"Eudragit Acrylic Polymers for Pharmaceutical Applications. R\u00f6hm Deguss-H\u00fcls Group. Pharma Polymers. Available online: https:\/\/www.pharmaceuticalonline.com\/doc\/rohm-america-0003. Accessed 9 Feb 2023."},{"key":"3517_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0928-0987(95)00049-6","volume":"4","author":"S Rossi","year":"1996","unstructured":"Rossi S, Bonferoni MC, Ferrari F, Bertoni M, Caramella C. Characterization of mucin interaction with three viscosity grades of sodium carboxymethylcellulose. Comparison between rheological and tensile testing. Eur J Pharm Sci. 1996;4:189\u201396. https:\/\/doi.org\/10.1016\/0928-0987(95)00049-6.","journal-title":"Eur J Pharm Sci"},{"key":"3517_CR40","unstructured":"Test N\u25e6 437: Bovine corneal opacity and permeability test method for identifying i) Chemicals inducing serious eye damage and ii) chemicals not requiring classification for eye irritation or serious eye damage. Paris: OECD Publishing; 2020."},{"key":"3517_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0275-5408(97)00066-5","volume":"21","author":"N Efron","year":"2001","unstructured":"Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt. 2001;21:17\u201329. https:\/\/doi.org\/10.1016\/s0275-5408(97)00066-5.","journal-title":"Ophthalmic Physiol Opt"},{"key":"3517_CR42","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/biomedicines12071584","volume":"12","author":"X Yang","year":"2024","unstructured":"Yang X, Gu P, Jiang Q, Cheng X, Fan J, Bai Y. Instant and multifunctional nanofibers loaded with proanthocyanidins and hyaluronic acid for skincare applications. Biomedicines. 2024;12:1584. https:\/\/doi.org\/10.3390\/biomedicines12071584.","journal-title":"Biomedicines"},{"key":"3517_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/bmb\/ldv002","volume":"113","author":"H Abdelkader","year":"2015","unstructured":"Abdelkader H, Pierscionek B, Carew M, Wu Z, Alany RG. Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals. Br Med Bull. 2015;113:59\u201371. https:\/\/doi.org\/10.1093\/bmb\/ldv002.","journal-title":"Br Med Bull"},{"key":"3517_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/026119290803600305","volume":"36","author":"EN Alves","year":"2008","unstructured":"Alves EN, Presgrave RF, Presgrave OA, Sabagh FP, de Freitas JC, Corrado AP. A reassessment of the in vitro RBC hemolysis assay with defibrinated sheep blood for the determination of the ocular irritation potential of cosmetic products: comparison with the in vivo Draize rabbit test. Altern Lab Anim. 2008;36:275\u201384. https:\/\/doi.org\/10.1177\/026119290803600305.","journal-title":"Altern Lab Anim"},{"key":"3517_CR45","unstructured":"Garrido L, Ibarra L, Marco C. Ciencia y tecnolog\u00eda de materiales polim\u00e9ricos, vol. I, 205-220. Garrido L, Ibarra L, Marco C, editors. Spain: ICTP-CSIC; 2004."},{"key":"3517_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.reactfunctpolym.2016.01.011","volume":"100","author":"S Mansuri","year":"2016","unstructured":"Mansuri S, Kesharwani P, Jain K, Tekade RK, Jain NK. Mucoadhesion: a promising approach in drug delivery system. React Funct Polym. 2016;100:151\u201372. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2016.01.011.","journal-title":"React Funct Polym"},{"key":"3517_CR47","doi-asserted-by":"publisher","first-page":"104596","DOI":"10.1016\/j.jddst.2023.104596","volume":"85","author":"K Mfoafo","year":"2023","unstructured":"Mfoafo K, Mittal R, Eshraghi A, Omidi Y, Omidian H. Thiolated polymers: an overview of mucoadhesive properties and their potential in drug delivery via mucosal tissues. J Drug Deliv Sci Tec. 2023;85:104596. https:\/\/doi.org\/10.1016\/j.jddst.2023.104596.","journal-title":"J Drug Deliv Sci Tec"},{"key":"3517_CR48","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","volume":"57","author":"A Ludwig","year":"2005","unstructured":"Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57:1595\u2013639. https:\/\/doi.org\/10.1016\/j.addr.2005.07.005.","journal-title":"Adv Drug Deliv Rev"},{"key":"3517_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12:348\u201360. https:\/\/doi.org\/10.1208\/s12248-010-9183-3.","journal-title":"AAPS J."},{"key":"3517_CR50","doi-asserted-by":"crossref","unstructured":"Hornyak GL, Moore JJ, Tibbals HF, Dutta J. Fundamentals of nanotechnology, 1st ed. Boca Raton: CRC Press; 2018.","DOI":"10.1201\/9781315222561"},{"key":"3517_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejps.2013.04.012","volume":"50","author":"I Pepi\u0107","year":"2013","unstructured":"Pepi\u0107 I, Lovri\u0107 J, Filipovi\u0107-Grci\u0107 J. How do polymeric micelles cross epithelial barriers? Eur J Pharm Sci. 2013;50:42\u201355. https:\/\/doi.org\/10.1016\/j.ejps.2013.04.012.","journal-title":"Eur J Pharm Sci"},{"key":"3517_CR52","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jconrel.2022.07.019","volume":"349","author":"M Ghezzi","year":"2022","unstructured":"Ghezzi M, Ferraboschi I, Delledonne A, Pescina S, Padula C, Santi P, et al. Cyclosporine-loaded micelles for ocular delivery: investigating the penetration mechanisms. J Control Release. 2022;349:744\u201355. https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.019.","journal-title":"J Control Release"},{"key":"3517_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-3155-12-5","volume":"12","author":"L Shang","year":"2014","unstructured":"Shang L, Nienhaus K, Nienhaus GU. Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol. 2014;12:5. https:\/\/doi.org\/10.1186\/1477-3155-12-5.","journal-title":"J Nanobiotechnol"},{"key":"3517_CR54","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.21608\/EJHM.2023.284303","volume":"90","author":"RA Al-Rubaye","year":"2023","unstructured":"Al-Rubaye RA, Al-Kinani KK. Formulation and evaluation of prednisolone acetate microemulsion ocular gel. Egypt J Hosp Med. 2023;90:1744\u201351. https:\/\/doi.org\/10.21608\/EJHM.2023.284303.","journal-title":"Egypt J Hosp Med"},{"key":"3517_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.addr.2012.04.010","volume":"65","author":"P Couvreur","year":"2013","unstructured":"Couvreur P. Nanoparticles in drug delivery: past, present and future. Adv Drug Deliv Rev. 2013;65:21\u20133. https:\/\/doi.org\/10.1016\/j.addr.2012.04.010.","journal-title":"Adv Drug Deliv Rev"},{"key":"3517_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12553-019-00381-w","volume":"10","author":"N Omerovi\u0107","year":"2020","unstructured":"Omerovi\u0107 N, Vrani\u0107 E. Application of nanoparticles in ocular drug delivery systems. Health Technol. 2020;10:61\u201378. https:\/\/doi.org\/10.1007\/s12553-019-00381-w.","journal-title":"Health Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03517-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03517-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:39:35Z","timestamp":1789148375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03517-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03517-0","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process.During the preparation of this work the authors used ChatGPT (OpenAI) in order to assist in refining the language and improving the clarity of the text. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":1,"name":"Ethics","label":"Declarations","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"292"}}